Blueberry THC Distillate is manufactured via an advanced multi-stage isolation process engineered to concentrate Delta-9-Tetrahydrocannabinol while completely stripping away non-therapeutic ballast, including chlorophyll, plant lipids, waxes, and volatile solvents. Initial raw crude oil is extracted utilizing sub-zero cryogenic ethanol, followed by multi-stage winterization and sub-micron filtration to achieve high clarirty. The purified extract undergoes controlled thermal vacuum decarboxylation prior to fractional wiped-film short-path distillation, separating cannabinoid fractions under high vacuum to produce a pure, golden cannabinoid resin.

Following distillation, the ultra-pure distillate is homogenously blended with a standardized 3.0% to 5.0% natural Blueberry terpene profile dominated by Beta-Myrcene, Beta-Caryophyllene, and Linalool. This precise formulation ensures organoleptic batch-to-batch reproducibility, optimizes fluid dynamics for medical vaporizers, and supports clinical therapeutic efficacy through the entourage effect. Across European medical cannabis frameworks—notably Germany under the CanG framework, the United Kingdom, and Poland—Blueberry THC Distillate is widely prescribed for nocturnal pain relief, sleep-onset insomnia, palliative oncology support, and severe muscular spasms.